Institutional Repository of Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences
| Selectivity, cell permeability and oral availability studies of novel bromophenol derivative HPN as protein tyrosine phosphatase 1B inhibitor | |
| Luo, Jiao1,2,3; Xu, Qi1,2,3; Jiang, Bo1,2; Zhang, Renshuai1,2; Jia, Xiaoling1,2; Li, Xiangqian1,2; Wang, Lijun1,2; Guo, Chuanlong1,2,3; Wu, Ning1,2; Shi, Dayong1,2,3 | |
| 2018 | |
| 发表期刊 | BRITISH JOURNAL OF PHARMACOLOGY
 |
| ISSN | 0007-1188 |
| 卷号 | 175期号:1页码:140-153 |
| 通讯作者 | Shi, Dayong(shidayong@qdio.ac.cn) |
| 摘要 | BACKGROUND AND PURPOSE Protein tyrosine phosphatase 1B (PTP1B) negatively regulates insulin signalling by tyrosine dephosphorylation of the insulin receptor. It is a highly validated target for type 2 diabetes therapeutics. Here, the anti-diabetic effects of HPN were evaluated in the diabetic BKS db mice. EXPERIMENTAL APPROACH The mode of inhibition of PTP1B by HPN was determined according to the Lineweaver-Burk plot. A surface plasmon resonance assay and molecular docking were used to study the interaction between HPN and PTP1B. C2C12 skeletal muscle cells were used to investigate the cell permeability of HPN and the effect of HPN on insulin signalling pathways. Long-term effects of HPN on glycaemic control were investigated in diabetic BKS db mice. Glycogen contents in liver and muscle were determined. Furthermore, changes in the number of beta cells were evaluated by Gomori staining. KEY RESULTS HPN was identified as a specific PTP1B inhibitor. HPN directly interacted with PTP1B by binding to the catalytic domain through hydrogen bonds in a competitive mode. Approximately 56.98% of HPN entered into the cultured C2C12 myotubes. HPN ameliorated the impaired insulin signalling in palmitate-treated C2C12 myocytes. Notably, oral administration of HPN significantly protected mice from hyperglycaemia, dyslipidemia and hyperinsulinaemia. HPN also enhanced the storage of glycogen in liver and muscle. Moreover, HPN obviously improved the beta cell numbers of the pancreatic islets. CONCLUSION AND IMPLICATIONS Our results indicate that HPN is a specific PTP1B inhibitor, with anti-diabetic properties and good cell permeability and oral availability. |
| DOI | 10.1111/bph.14080 |
| 收录类别 | SCI |
| 语种 | 英语 |
| 资助项目 | Shandong Provincial Natural Science Foundation for Distinguished Young Scholars[JQ201722] ; National Natural Science Foundation of China[81773586] ; National Natural Science Foundation of China[81703354] ; Key research and development project of Shandong province[2016ZDJS07A13] ; Key research and development project of Shandong province[2016GSF115002] ; Key research and development project of Shandong province[2016GSF201193] ; Key research and development project of Shandong province[2016GSF115009] ; Key Research Program of Frontier Sciences, CAS[QYZDB-SSW-DQC014] ; Project of Discovery, Evaluation and Transformation of Active Natural Compounds, Strategic Biological Resources Service Network Programme of Chinese Academy of Sciences[ZSTH-026] ; NSFC-Shandong Joint Fund for Marine Science Research Centres[U1606403] ; Scientific and Technological Innovation Project - Qingdao National Laboratory for Marine Science and Technology[2015ASKJ02] ; Qingdao National Laboratory for Marine Science and Technology[2015ASTP] ; National Program for Support of Top-notch Young Professionals and Taishan scholar Youth Project of Shandong province ; Shandong Provincial Natural Science Foundation for Distinguished Young Scholars[JQ201722] ; National Natural Science Foundation of China[81773586] ; National Natural Science Foundation of China[81703354] ; Key Research and Development Project of Shandong Province[2016ZDJS07A13] ; Key Research and Development Project of Shandong Province[2016GSF115002] ; Key Research and Development Project of Shandong Province[2016GSF201193] ; Key Research and Development Project of Shandong Province[2016GSF115009] ; Key Research Program of Frontier Sciences, CAS[QYZDB-SSW-DQC014] ; Project of Discovery, Evaluation and Transformation of Active Natural Compounds, Strategic Biological Resources Service Network Programme of Chinese Academy of Sciences[ZSTH-026] ; NSFC-Shandong Joint Fund for Marine Science Research Centres[U1606403] ; Scientific and Technological Innovation project - Qingdao National Laboratory for Marine Science and Technology[2015ASKJ02] ; Qingdao National Laboratory for Marine Science and Technology[2015ASTP] ; National Program for Support of Top-notch Young Professionals and Taishan scholar Youth Project of Shandong province |
| WOS研究方向 | Pharmacology & Pharmacy |
| WOS类目 | Pharmacology & Pharmacy |
| WOS记录号 | WOS:000418678600011 |
| 出版者 | WILEY |
| 引用统计 | |
| 文献类型 | 期刊论文 |
| 条目标识符 | http://ir.qdio.ac.cn/handle/337002/157784 |
| 专题 | 实验海洋生物学重点实验室 |
| 通讯作者 | Shi, Dayong |
| 作者单位 | 1.Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, 7 Nanhai Rd, Qingdao 266071, Peoples R China 2.Qingdao Natl Lab Marine Sci & Technol, Lab Marine Drugs & Bioprod, Qingdao, Peoples R China 3.Univ Chinese Acad Sci, Beijing, Peoples R China |
| 第一作者单位 | 中国科学院海洋研究所 |
| 通讯作者单位 | 中国科学院海洋研究所 |
| 推荐引用方式 GB/T 7714 | Luo, Jiao,Xu, Qi,Jiang, Bo,et al. Selectivity, cell permeability and oral availability studies of novel bromophenol derivative HPN as protein tyrosine phosphatase 1B inhibitor[J]. BRITISH JOURNAL OF PHARMACOLOGY,2018,175(1):140-153. |
| APA | Luo, Jiao.,Xu, Qi.,Jiang, Bo.,Zhang, Renshuai.,Jia, Xiaoling.,...&Shi, Dayong.(2018).Selectivity, cell permeability and oral availability studies of novel bromophenol derivative HPN as protein tyrosine phosphatase 1B inhibitor.BRITISH JOURNAL OF PHARMACOLOGY,175(1),140-153. |
| MLA | Luo, Jiao,et al."Selectivity, cell permeability and oral availability studies of novel bromophenol derivative HPN as protein tyrosine phosphatase 1B inhibitor".BRITISH JOURNAL OF PHARMACOLOGY 175.1(2018):140-153. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
| Selectivity, cell pe（2211KB） | 期刊论文 | 出版稿 | 限制开放 | CC BY-NC-SA | 浏览 | |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论